← All research updates

Gallium maltolate taken by mouth for glioblastoma that has come back

Original title: Oral Gallium Maltolate for Recurrent Glioblastoma

How far along is this research?

This is a trial that is enrolling or has been updated. It is not a finding yet.

This is a very early study in people, done to see if the drug reaches the tumor.

Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.

The trial team last updated this record on . Always check the trial page for the latest.

The short version

This trial checks whether a drug taken by mouth reaches brain tumor tissue.

Who this trial is for. This trial is for people whose glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary has come back. They take gallium maltolate by mouth before surgery. The trial measures how much gallium reaches the brain and the tumor.

Where it stands. This trial has not reported results. It is measuring how much of the drug gets into the brain and into tumor tissue. That answer is not in yet.

What this means, and what it doesn't

What it could mean: This is an early step to learn if the drug can even reach a brain tumor. It does not yet tell us if it helps anyone live longer or feel better. Someone whose tumor has come back could ask their care team if this study fits them.

What it doesn't mean: This does not mean gallium maltolate treats glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary. A trial is a test, not a proven treatment. Joining one is not a guarantee of any benefit. It is not a promise of a cure. Whether anyone can join is decided by the trial team.

Source: ClinicalTrials.gov, September 23, 2026 · Read the original

This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.

Report a problem with this summary